Kennen Sie schon unseren Geschäftskundenservice? Wir beraten Sie gerne.
Fokusthemen
Publikationen
Services
Autorinnen/Autoren
Verlag
Shop
LEXIA
Zeitschriften
SachbuchLOKISemaphor
Treatment of Cystic Fibrosis and Other Rare Lung Diseases

Treatment of Cystic Fibrosis and Other Rare Lung Diseases

Inhalt

This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival andquality of life for affected individuals.


Bibliografische Angaben

Februar 2017, 263 Seiten, Milestones in Drug Therapy, Englisch
Springer Nature EN
978-3-0348-0975-7

Inhaltsverzeichnis

Schlagworte

Weitere Titel der Reihe: Milestones in Drug Therapy

Alle anzeigen

Weitere Titel zum Thema